The FDA Approves the First-Ever Gene Therapy for Deafness, Which Aims to Restore Hearing in Kids With a Rare Inherited Condition
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the pediatric participants. However, Deaf community advocates worry about the push to cure hearing loss
Original Source
Read the full article at Smithsonianmag →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.